Pierre Auguste Renoir Dance at Bougival I painting

Pierre Auguste Renoir Dance at Bougival I painting
Thomas Kinkade Stairway to Paradise painting
Roslin's researchers say avian technology promises much faster and cheaper drug production since chickens lay so many eggs in a day. It's estimated that one genetically modified hen could lay about 250 eggs a year."Now that the human genome has been mapped, hundreds of new, novel and powerful protein and monoclonal antibody drugs are under development or proceeding through clinical trials," says Magnus Nicolson, the CEO of Viragen. "This explosion has accelerated the need for expanded production facilities."Roslin and Viragen aren't the first research groups to pursue egg pharming. At least three U.S. companies and one British company are racing to turn poultry into drug factories. One American company, AviGenic,s claims to have already created transgenic roosters that pass on human genes to chicks. The genes create substances that are used against hepatitis and some cancers.News of the deal that was announced at Edinburgh Castle was leaked in British newspapers during the weekend, along with news that Britney, reportedly one of a flock of genetically modified birds, would make an appearance.